These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 15979100)
1. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis. Jung HC; Kim K Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin. Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053 [TBL] [Abstract][Full Text] [Related]
3. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Gustavson MD; Crawford HC; Fingleton B; Matrisian LM Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508 [TBL] [Abstract][Full Text] [Related]
4. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Hämmerlein A; Weiske J; Huber O Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065 [TBL] [Abstract][Full Text] [Related]
5. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505 [TBL] [Abstract][Full Text] [Related]
6. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S; Bapat B Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999 [TBL] [Abstract][Full Text] [Related]
7. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729 [TBL] [Abstract][Full Text] [Related]
8. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development. Schmidt M; Patterson M; Farrell E; Münsterberg A Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726 [TBL] [Abstract][Full Text] [Related]
9. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype. Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042 [TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745 [TBL] [Abstract][Full Text] [Related]
11. Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells. Marchenko ND; Marchenko GN; Weinreb RN; Lindsey JD; Kyshtoobayeva A; Crawford HC; Strongin AY Int J Biochem Cell Biol; 2004 May; 36(5):942-56. PubMed ID: 15006646 [TBL] [Abstract][Full Text] [Related]
12. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1). Asally M; Yoneda Y Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755 [TBL] [Abstract][Full Text] [Related]
13. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974 [TBL] [Abstract][Full Text] [Related]
14. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M; Nakamura Y; Obama K; Furukawa Y Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202 [TBL] [Abstract][Full Text] [Related]
15. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line. Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054 [TBL] [Abstract][Full Text] [Related]
16. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma. Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435 [TBL] [Abstract][Full Text] [Related]
17. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737 [TBL] [Abstract][Full Text] [Related]
18. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259 [TBL] [Abstract][Full Text] [Related]
19. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function. Kim K; Lee KY Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]